Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Basic treatment
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Beet It Sport Shot
Aspire Biopharma Holdings
Blood Pressure
1 trial -
Benazepril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Renal Insufficiency,Chronic
1 trial -
Best medical management
The First People's Hospital of Lianyungang
Stroke, Ischemic
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Brain Glioma
1 trial -
Bifidobacterium
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
Biobran supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Stages I
1 trial -
Bivalirudin
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-ALL
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adult ALL
1 trial -
Botulinum Toxin Type A Injection [Botox]
The First People's Hospital of Lianyungang
Rosacea
1 trial -
Breast MRI interpretation
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Breztri Aerosphere
The First People's Hospital of Lianyungang
Lung Cancer, Nonsmall Cell
1 trial -
Bromocriptin 2.5mg, 2-3 times a day
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pituitary Tumor
1 trial -
Budesonide/formoterol
The First People's Hospital of Lianyungang
COPD Exacerbation
1 trial -
Bufei Recipe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Preserved Ratio Impaired Spirometry
1 trial -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
Bupivacain
Hospital Authority, Hong Kong
Arthroplasty, Replacement, Knee
1 trial -
Buspirone
The First People's Hospital of Lianyungang
Anxiety Disorders
1 trial -
Buspirone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorders
1 trial -
Butorphanol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visceral Pain
1 trial -
Buyang Huanwu Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glaucoma
1 trial -
CAPA-IVM
Hospital Authority, Hong Kong
Infertility, Female
1 trial -
CAR-CD19 T cell
The First People's Hospital of Lianyungang
B Cell Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources